Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aldeyra Therapeutics Inc. (ALDX) (ALDX)

2.405   -0.135 (-5.31%) 03-30 10:15
Open: 2.09 Pre. Close: 2.54
High: 2.51 Low: 2.33
Volume: 21,030 Market Cap: 71M
Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.633 - 2.644 2.644 - 2.654
Low: 2.068 - 2.078 2.078 - 2.087
Close: 2.522 - 2.54 2.54 - 2.557

Technical analysis

as of: 2020-03-30 10:02:40 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.20     One year: 5.72
Support: Support1: 1.48    Support2: 1.23
Resistance: Resistance1: 3.59    Resistance2: 4.90
Pivot: 2.24
Moving Average: MA(5): 2.32     MA(20): 2.55
MA(100): 5.06     MA(250): 5.79
MACD: MACD(12,26): -0.57     Signal(9): -0.69
Stochastic oscillator: %K(14,3): 46.62     %D(3): 38.88
RSI: RSI(14): 41.38
52-week: High: 9.11  Low: 1.48  Change(%): -71.7
Average Vol(K): 3-Month: 21937  10-Days: 31016

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ALDX has closed below upper band by 37.6%. Bollinger Bands are 15.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.

Aldeyra Therapeutics Reports Full-Year 2019 Financial Results
Aldeyra Therapeutics reported financial results for the year ended December 31, 2019 and provided an update on anticipated clinical milestones. The post Aldeyra Therapeutics Reports Full-Year 2019 Financial Results appeared first on Investing News Network .

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 27.95
Shares Float (M) 20.60
% Held by Insiders 4.08
% Held by Institutions 66.07
Shares Short (K) 437
Shares Short P. Month (K) 522

Stock Financials

EPS -2.244
Book Value (p.s.) 1.680
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -41.4
Return on Equity (ttm) -90.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.018
Qtrly Earnings Growth
Operating Cash Flow (M) -44.98
Levered Free Cash Flow (M) -7.70

Stock Valuations

P/E -1.08
P/E Growth Ratio -0.04
P/BV 1.45
P/CF -1.51

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.